Investor Ideas Updates #Cannabis /
#Hemp #Stock Directory as Legalization
in Canada Approaches
#Hemp #Stock Directory as Legalization
in Canada Approaches
Delta, Kelowna, BC –September 12, 2018
(Investorideas.com Newswire) www.Investorideas.com, a global news source
covering leading sectors including marijuana and hemp stocks and its “potcast’
site, www.potcasts.ca , Investor Ideas #Potcasts #Cannabis News and Stocks
on the Move, issue the following stock directory preview and update for
investors following the sector.
(Investorideas.com Newswire) www.Investorideas.com, a global news source
covering leading sectors including marijuana and hemp stocks and its “potcast’
site, www.potcasts.ca , Investor Ideas #Potcasts #Cannabis News and Stocks
on the Move, issue the following stock directory preview and update for
investors following the sector.
Investor Ideas
stock directory of publicly traded CSE, TSX,
TSXV, OTC, NASDAQ, NYSE, ASX Marijuana / Hemp Stocks
stock directory of publicly traded CSE, TSX,
TSXV, OTC, NASDAQ, NYSE, ASX Marijuana / Hemp Stocks
Marijuana/Hemp Stocks Preview
22nd Century Group Inc. (NYSE MKT:XXII) is a plant biotechnology company focused on
technology which allows it to increase or decrease the level of nicotine in
tobacco plants and the level of cannabinoids in cannabis plants through genetic
engineering and plant breeding. The Company’s primary mission is to reduce the
harm caused by smoking. 22nd Century currently owns or exclusively controls
more than 200 issued patents and more than 50 pending patent applications
around the world. The Company’s strong IP position led to a licensing agreement
with British American Tobacco (“BAT”), the world’s second largest tobacco
company.
technology which allows it to increase or decrease the level of nicotine in
tobacco plants and the level of cannabinoids in cannabis plants through genetic
engineering and plant breeding. The Company’s primary mission is to reduce the
harm caused by smoking. 22nd Century currently owns or exclusively controls
more than 200 issued patents and more than 50 pending patent applications
around the world. The Company’s strong IP position led to a licensing agreement
with British American Tobacco (“BAT”), the world’s second largest tobacco
company.
3DX Industries
Inc. (OTC: DDDX) is focused on the
additive metal manufacturing segment within the manufacturing industry. 3DX has
the capability of manufacturing a wide variety of products using its 3D metal
printing system, 3D composite printing as well as more traditional methods of
precision manufacturing. 3DX offers additive and subtractive manufacturing
options as well as product design, engineering and assembly services to its
customers. Cannabis: Has completed the
development and design of a new and innovative product used for recovering
excess heat from high energy grow lights. The
part was designed specifically for the legalized cannabis markets including
medical marijuana using the company's 3D Metal printing -- Binder Additive
manufacturing process and is expected to be installed in select licensed
facilities for real world testing in the coming months.
Inc. (OTC: DDDX) is focused on the
additive metal manufacturing segment within the manufacturing industry. 3DX has
the capability of manufacturing a wide variety of products using its 3D metal
printing system, 3D composite printing as well as more traditional methods of
precision manufacturing. 3DX offers additive and subtractive manufacturing
options as well as product design, engineering and assembly services to its
customers. Cannabis: Has completed the
development and design of a new and innovative product used for recovering
excess heat from high energy grow lights. The
part was designed specifically for the legalized cannabis markets including
medical marijuana using the company's 3D Metal printing -- Binder Additive
manufacturing process and is expected to be installed in select licensed
facilities for real world testing in the coming months.
48North Cannabis Corp. (TSX:NRTH.V) is a TSXV
Venture Exchange listed company whose wholly owned subsidiary DelShen
Therapeutics Corp. ("DelShen"), is a licensed producer of medical
cannabis in Canada. 48North grows unique
genetics sourced from MariPharm B.V., a Netherlands-based phytopharmaceutical
company with over 25 years of experience in the research and cultivation of
cannabis for medical purposes. Its genetics are grown to exacting standards,
ensuring patients can count on receiving the highest-quality cannabis products.
DelShen is regulated by the Access to Cannabis for Medical Purposes Regulations
("ACMPR") and the facility is located on 800-acres of owned land near
Kirkland Lake, Ontario. DelShen's license
to produce cannabis was granted on Feb. 28, 2017, and pertains to the facility,
a state-of-the-art, closed-box, 40,000-square-foot building with an additional
Venture Exchange listed company whose wholly owned subsidiary DelShen
Therapeutics Corp. ("DelShen"), is a licensed producer of medical
cannabis in Canada. 48North grows unique
genetics sourced from MariPharm B.V., a Netherlands-based phytopharmaceutical
company with over 25 years of experience in the research and cultivation of
cannabis for medical purposes. Its genetics are grown to exacting standards,
ensuring patients can count on receiving the highest-quality cannabis products.
DelShen is regulated by the Access to Cannabis for Medical Purposes Regulations
("ACMPR") and the facility is located on 800-acres of owned land near
Kirkland Lake, Ontario. DelShen's license
to produce cannabis was granted on Feb. 28, 2017, and pertains to the facility,
a state-of-the-art, closed-box, 40,000-square-foot building with an additional
ABATTIS BIOCEUTICALS (OTC:ATTBF; CSE:ATT) is a specialty
biotechnology company with capabilities through its wholly owned subsidiaries
of cultivating, licensing and marketing proprietary ingredients, bio-similar
compounds, patented equipment and consulting services to medicinal markets in
North America. The Company is positioned to capitalize on the fast growing
trend toward marijuana legalization in the United States and for medicinal use
in Canada and international jurisdictions, by supplying and partnering with
companies to employ its mass cultivation systems, extraction
equipment/technology, and strategic marketing support to licensed growers. The
Company also has an extensive pipeline of high-quality products and
intellectual property for the rapidly expanding botanical drug market. We follow
strict standard operating protocols, and adhere to the applicable laws of
Canada and foreign jurisdictions.
biotechnology company with capabilities through its wholly owned subsidiaries
of cultivating, licensing and marketing proprietary ingredients, bio-similar
compounds, patented equipment and consulting services to medicinal markets in
North America. The Company is positioned to capitalize on the fast growing
trend toward marijuana legalization in the United States and for medicinal use
in Canada and international jurisdictions, by supplying and partnering with
companies to employ its mass cultivation systems, extraction
equipment/technology, and strategic marketing support to licensed growers. The
Company also has an extensive pipeline of high-quality products and
intellectual property for the rapidly expanding botanical drug market. We follow
strict standard operating protocols, and adhere to the applicable laws of
Canada and foreign jurisdictions.
ABcann Global Corporation (TSX:ABCN.V) was one of the first companies to obtain a production
license under the Marijuana for Medical Purposes Regulations, which it received
on March 21, 2014. It obtained a sales license on December 31, 2015. ABcann’s
flagship facility, in Napanee, Ontario, contains proprietary plant-growing
technology, including environmentally-controlled chambers capable of monitoring
and regulating all variables in the growing process. This approach and the
systems in place allow ABcann to produce organically grown and pesticide-free,
high-yielding plants, which, in turn, can generate high-quality products that
are consistent from batch to batch. ABcann is able to control environmental and
nutrient demands, tailor-made for a particular strain of cannabis, without the
variation that is typical when producing large quantities in less-controlled,
larger rooms and greenhouse-type structures. ABcann’s modular approach to
systems technology eliminates scale-up risk and allows ABcann to locate
anywhere in the world and maintain consistency and quality of product. ABcann
is expanding capacity in its current facility to approximately 30,000 sq ft and
concurrently undertaking expansion into a new 150,000 sq ft facility in
Napanee. ABcann is pursuing opportunities in Germany, Australia and other
jurisdictions as well as exploring the development of multiple delivery
vehicles.
license under the Marijuana for Medical Purposes Regulations, which it received
on March 21, 2014. It obtained a sales license on December 31, 2015. ABcann’s
flagship facility, in Napanee, Ontario, contains proprietary plant-growing
technology, including environmentally-controlled chambers capable of monitoring
and regulating all variables in the growing process. This approach and the
systems in place allow ABcann to produce organically grown and pesticide-free,
high-yielding plants, which, in turn, can generate high-quality products that
are consistent from batch to batch. ABcann is able to control environmental and
nutrient demands, tailor-made for a particular strain of cannabis, without the
variation that is typical when producing large quantities in less-controlled,
larger rooms and greenhouse-type structures. ABcann’s modular approach to
systems technology eliminates scale-up risk and allows ABcann to locate
anywhere in the world and maintain consistency and quality of product. ABcann
is expanding capacity in its current facility to approximately 30,000 sq ft and
concurrently undertaking expansion into a new 150,000 sq ft facility in
Napanee. ABcann is pursuing opportunities in Germany, Australia and other
jurisdictions as well as exploring the development of multiple delivery
vehicles.
Acology Inc (OTC:ACOL) markets and
sells the TSOS Container™ (The Science of Storage).This container is the
first-ever FDA approved polypropylene air-tight, water-tight, smell-proof
delivery and storage container with a built-in grinder. It is manufactured from
medical-grade No. 5 polypropylene resin, which is non-porous and non-leaching.
These containers are portable and affordable. he Medtainer™ allows patients to
store, grind and pour a variety of medications, including pills and all sizes
and solidity, herbal medications and teas and even coffee and spices! The
Medtainer™ can be ordered in with a certified child-resistant cap. Each
Medtainer™ is water-proof and smell proof. Caregivers who are responsible for
ensuring their patients medication regimens are universally pleased with the
how easy and effective the Medtainer™ grind medications. It is an excellent
solution for patients with dysphasia due to cognitive disorders or brain
injuries, are in hospice or palliative situations and for anyone who would
rather not swallow whole pills. The MedTainer™ was originally developed for
geriatric and pediatric patients who had difficulty swallowing pills or needed
an effective alternative to costly name-brand medications. The MedTainer™ has
been sold and is being successfully used throughout the United States, Canada,
Mexico and South America and Europe. Our association with the Medical Marijuana
community was an unexpected windfall that has given Acology, Inc. the necessary
funding to expand into the growing hospice and palliative care markets, and to
help countless patients who are living at home or in small home-like settings
and need help swallowing pills.
sells the TSOS Container™ (The Science of Storage).This container is the
first-ever FDA approved polypropylene air-tight, water-tight, smell-proof
delivery and storage container with a built-in grinder. It is manufactured from
medical-grade No. 5 polypropylene resin, which is non-porous and non-leaching.
These containers are portable and affordable. he Medtainer™ allows patients to
store, grind and pour a variety of medications, including pills and all sizes
and solidity, herbal medications and teas and even coffee and spices! The
Medtainer™ can be ordered in with a certified child-resistant cap. Each
Medtainer™ is water-proof and smell proof. Caregivers who are responsible for
ensuring their patients medication regimens are universally pleased with the
how easy and effective the Medtainer™ grind medications. It is an excellent
solution for patients with dysphasia due to cognitive disorders or brain
injuries, are in hospice or palliative situations and for anyone who would
rather not swallow whole pills. The MedTainer™ was originally developed for
geriatric and pediatric patients who had difficulty swallowing pills or needed
an effective alternative to costly name-brand medications. The MedTainer™ has
been sold and is being successfully used throughout the United States, Canada,
Mexico and South America and Europe. Our association with the Medical Marijuana
community was an unexpected windfall that has given Acology, Inc. the necessary
funding to expand into the growing hospice and palliative care markets, and to
help countless patients who are living at home or in small home-like settings
and need help swallowing pills.
Advantis Corp (OTC:ADVT) develops products and works with developing
companies to provide innovative healthcare products, holistic pain management
solutions, and enhance the footprint in the evolving legal cannabis business.
Advantis acquires ownership in developing companies that work within the
nutraceutical and the alternative health care industries; consulting with these
organizations to improve their product lines, expand their distribution
channels through internal partnership agreements, and heighten brand value.
companies to provide innovative healthcare products, holistic pain management
solutions, and enhance the footprint in the evolving legal cannabis business.
Advantis acquires ownership in developing companies that work within the
nutraceutical and the alternative health care industries; consulting with these
organizations to improve their product lines, expand their distribution
channels through internal partnership agreements, and heighten brand value.
Aequus Pharmaceuticals
Inc. (TSX:AQS.V) (OTCQB:
AQSZF) is a growing specialty pharmaceutical company
focused on developing and commercializing high quality, differentiated
products. Aequus has grown its pipeline to include several commercial products
in ophthalmology and transplant, and a development stage pipeline in neurology
and psychiatry with a goal of addressing the need for improved medication
adherence through enhanced delivery systems. As a complement to its focus in
neurology, our most recent addition to the development pipeline was a
long-acting form of medical cannabis, where there is a high need for a
consistent, predictable and pharmaceutical-grade delivery of products for
patients. Aequus intends to commercialize its internal programs in Canada
alongside its current portfolio of marketed established medicines and will look
to form strategic partnerships that would maximize the reach of its product
candidates worldwide. Aequus plans to build on its Canadian commercial platform
through the launch of additional products that are either created internally or
brought in through an acquisition or license; remaining focused on highly
specialized therapeutic areas. For further information, please visit
Inc. (TSX:AQS.V) (OTCQB:
AQSZF) is a growing specialty pharmaceutical company
focused on developing and commercializing high quality, differentiated
products. Aequus has grown its pipeline to include several commercial products
in ophthalmology and transplant, and a development stage pipeline in neurology
and psychiatry with a goal of addressing the need for improved medication
adherence through enhanced delivery systems. As a complement to its focus in
neurology, our most recent addition to the development pipeline was a
long-acting form of medical cannabis, where there is a high need for a
consistent, predictable and pharmaceutical-grade delivery of products for
patients. Aequus intends to commercialize its internal programs in Canada
alongside its current portfolio of marketed established medicines and will look
to form strategic partnerships that would maximize the reach of its product
candidates worldwide. Aequus plans to build on its Canadian commercial platform
through the launch of additional products that are either created internally or
brought in through an acquisition or license; remaining focused on highly
specialized therapeutic areas. For further information, please visit
AeroGrow International, Inc. (OTC:AERO) Headquartered in
Boulder, Colorado, AeroGrow International, Inc. is the leader in the rapidly
growing indoor gardening category. AeroGardens allow anyone to grow farmer's
market fresh herbs, salad greens, tomatoes, chili peppers, flowers and more,
indoors, year-round, so simply and easily that no green thumb is required. With
an AeroGarden... you can grow anything! In April 2013, AeroGrow entered into a
strategic partnership with Scotts Miracle-Gro to continue to expand the indoor
gardening market.
Boulder, Colorado, AeroGrow International, Inc. is the leader in the rapidly
growing indoor gardening category. AeroGardens allow anyone to grow farmer's
market fresh herbs, salad greens, tomatoes, chili peppers, flowers and more,
indoors, year-round, so simply and easily that no green thumb is required. With
an AeroGarden... you can grow anything! In April 2013, AeroGrow entered into a
strategic partnership with Scotts Miracle-Gro to continue to expand the indoor
gardening market.
AFFINOR GROWERS (CSE:AFI; OTC:RSSFF) is focused on growing high quality crops such as
romaine lettuce, spinach, strawberries and high quality medical Marijuana.
Affinor is committed to becoming a pre-eminent grower, using exclusive vertical
farming techniques.
romaine lettuce, spinach, strawberries and high quality medical Marijuana.
Affinor is committed to becoming a pre-eminent grower, using exclusive vertical
farming techniques.
Agritek Holdings Inc (OTC:AGTK) a fully
reporting Company and pioneer within the medicinal marijuana space provides
innovative patient and agricultural solutions seeks to be the leader in Compassionate
Care Technology for the medicinal marijuana industry. Agritek Holdings provides
real estate management and health and wellness product lines through its
wholly-owned subsidiary, Agritek Holdings Inc.
Agritek Holdings Inc. does not directly grow, harvest, or distribute or
sell cannabis or any substances that violate United States law or the
Controlled Substances Act, nor does it intend to do so in the future.
reporting Company and pioneer within the medicinal marijuana space provides
innovative patient and agricultural solutions seeks to be the leader in Compassionate
Care Technology for the medicinal marijuana industry. Agritek Holdings provides
real estate management and health and wellness product lines through its
wholly-owned subsidiary, Agritek Holdings Inc.
Agritek Holdings Inc. does not directly grow, harvest, or distribute or
sell cannabis or any substances that violate United States law or the
Controlled Substances Act, nor does it intend to do so in the future.
Aleafia Health Inc. (TSXV: ALEF.V; OTCQX: ALEAF) is one of Canada's leading,
vertically integrated medical cannabis companies with a unique patient-focused,
medical cannabis healthcare solution. Led by a distinguished and experienced
corporate leadership team, Aleafia Health Inc. is pioneering a patient-centric
experience that includes personalized services before, during and after
treatment. Aleafia's 22 cannabis clinics are staffed by licensed, practicing
physicians. Aleafia Health Inc. has realized sustained patient acquisition
growth and retention, underscoring the success of Canada's first
"patient-centric" cannabis-based health network.
vertically integrated medical cannabis companies with a unique patient-focused,
medical cannabis healthcare solution. Led by a distinguished and experienced
corporate leadership team, Aleafia Health Inc. is pioneering a patient-centric
experience that includes personalized services before, during and after
treatment. Aleafia's 22 cannabis clinics are staffed by licensed, practicing
physicians. Aleafia Health Inc. has realized sustained patient acquisition
growth and retention, underscoring the success of Canada's first
"patient-centric" cannabis-based health network.
ALGAE DYNAMICS CORP (OTCQB: ADYNF) ADC is engaged in the development of unique
health products and nutraceuticals that utilize hemp, cannabis and algae oils.
We have engaged two Canadian universities to provide research into the use of
extracts from cannabis oil, which we plan to use to develop products that
combine the significant health benefits of Omega-3s derived from algae oil and
extracts from cannabis oil. Our research is focused on the use of cannabis oil
in the context of cancer, and the use of cannabis derivatives for the
development of novel pharmacotherapies for mental health.
health products and nutraceuticals that utilize hemp, cannabis and algae oils.
We have engaged two Canadian universities to provide research into the use of
extracts from cannabis oil, which we plan to use to develop products that
combine the significant health benefits of Omega-3s derived from algae oil and
extracts from cannabis oil. Our research is focused on the use of cannabis oil
in the context of cancer, and the use of cannabis derivatives for the
development of novel pharmacotherapies for mental health.
Algae.Tec (ASX: AEB.AX) is a
specialist producer, focused on developing technology that captures waste
carbon dioxide to produce commercial quantities of a range of plant derived
products for supply to three key markets: Medicinal cannabis, Algae-based
nutraceuticals and Animal feed and aquaculture markets.
specialist producer, focused on developing technology that captures waste
carbon dioxide to produce commercial quantities of a range of plant derived
products for supply to three key markets: Medicinal cannabis, Algae-based
nutraceuticals and Animal feed and aquaculture markets.
Alliance Growers Corp. (CSE:ACG) is a cannabis
company dedicated to building shareholder value through its 4 Pillars business
strategy. The company was incorporated in 2014 and is publicly traded on the
CSE under the symbol ACG. The company’s head office is in Vancouver, BC and its
interest in a marijuana production facility in Kelowna, BC.
company dedicated to building shareholder value through its 4 Pillars business
strategy. The company was incorporated in 2014 and is publicly traded on the
CSE under the symbol ACG. The company’s head office is in Vancouver, BC and its
interest in a marijuana production facility in Kelowna, BC.
Alternate Health Corp. (CSE:AHG; OTC:ATEHF) is a
diversified healthcare company that uses its expertise in technology to
revolutionize patient care and service delivery in both traditional and
complementary medical fields. With investments in research, education and
cutting edge technology, Alternate Health is a leader in software applications
and processing systems for the medical industry using proprietary technology
platforms. Through its subsidiaries, Alternate Health offers services ranging
from medical practice and controlled substance management software to blood
analysis and toxicology labs, to clinical research and continuing education
programs. Alternate Health’s goal is to continue to lead the medical industry
with data-driven results in patient care and product development.
diversified healthcare company that uses its expertise in technology to
revolutionize patient care and service delivery in both traditional and
complementary medical fields. With investments in research, education and
cutting edge technology, Alternate Health is a leader in software applications
and processing systems for the medical industry using proprietary technology
platforms. Through its subsidiaries, Alternate Health offers services ranging
from medical practice and controlled substance management software to blood
analysis and toxicology labs, to clinical research and continuing education
programs. Alternate Health’s goal is to continue to lead the medical industry
with data-driven results in patient care and product development.
American Cannabis Company, Inc. (OTC:AMMJ) offers end-to-end solutions to existing and
aspiring participants in the cannabis industry. We utilize our industry
expertise to provide business planning and market assessment services, assist
state licensing procurement, create business infrastructure and operational
best practices. Through our two vertically integrated businesses, American
Cannabis Consulting and American Cultivator Company, a group purchasing
organization, we support our clients from concept to creation to
commercialization to on-going operations.
aspiring participants in the cannabis industry. We utilize our industry
expertise to provide business planning and market assessment services, assist
state licensing procurement, create business infrastructure and operational
best practices. Through our two vertically integrated businesses, American
Cannabis Consulting and American Cultivator Company, a group purchasing
organization, we support our clients from concept to creation to
commercialization to on-going operations.
American Green Inc (OTC:ERBB) Founded
back in 2009 as one of the first publicly-traded medical marijuana-related
companies in the world, American Green is proud to have the largest certified
shareholder base which now numbers well over 50,000. The Company is keenly
focused on developing, retailing, branding, and establishing commercial
cultivation solutions under its proprietary American Green name along with our
partners who are licensed retail medical marijuana dispensaries. American Green
believes that the renewal of the legalized cannabis industry in the United
States will aid in getting our economy back on its feet through increased
employment in all related sectors -- retail, real estate, contracting, farming
and more. Additional revenues, fueled by taxing cannabis sales, and the
decreased cost of housing prisoners who are no longer in prison for possession
of cannabis should contribute to the renewal. Hard work and a clear vision
propel American Green into the future. The centerpiece of our company is ZaZZZ,
our unique automated vending solution designed specifically around American
Green's licensed proprietary patent technology.
back in 2009 as one of the first publicly-traded medical marijuana-related
companies in the world, American Green is proud to have the largest certified
shareholder base which now numbers well over 50,000. The Company is keenly
focused on developing, retailing, branding, and establishing commercial
cultivation solutions under its proprietary American Green name along with our
partners who are licensed retail medical marijuana dispensaries. American Green
believes that the renewal of the legalized cannabis industry in the United
States will aid in getting our economy back on its feet through increased
employment in all related sectors -- retail, real estate, contracting, farming
and more. Additional revenues, fueled by taxing cannabis sales, and the
decreased cost of housing prisoners who are no longer in prison for possession
of cannabis should contribute to the renewal. Hard work and a clear vision
propel American Green into the future. The centerpiece of our company is ZaZZZ,
our unique automated vending solution designed specifically around American
Green's licensed proprietary patent technology.
American Premium Water
Corporation (OTC:HIPH) produces bottled water under the LALPINA brand name.LALPINA WATER is sourced from a high-altitude
aquifer deep in the Blue Ridge and the Blue Mountains. It is available in 7.3
and 9.5 pH, either natural spring or sparkling. American
Premium Water Corporation is based in Delray Beach, Florida.
Corporation (OTC:HIPH) produces bottled water under the LALPINA brand name.LALPINA WATER is sourced from a high-altitude
aquifer deep in the Blue Ridge and the Blue Mountains. It is available in 7.3
and 9.5 pH, either natural spring or sparkling. American
Premium Water Corporation is based in Delray Beach, Florida.
Americann Inc (OTC:ACAN) is a publicly
traded company that plans to develop and lease sustainable, state-of-the-art
medical cannabis cultivation properties. The Company has over 1,000,000 square
feet of facilities in the planning and design stages of development. The
Company has designed a proprietary line of cannabis infused products which will
be branded and licensed to companies in regulated markets. AmeriCann, Inc. is a
Certified B Corp, an acknowledgment of the company's commitment to social and
environmental ethics, transparency and accountability. AmeriCann became the
first public cannabis company to earn this respected accreditation.
traded company that plans to develop and lease sustainable, state-of-the-art
medical cannabis cultivation properties. The Company has over 1,000,000 square
feet of facilities in the planning and design stages of development. The
Company has designed a proprietary line of cannabis infused products which will
be branded and licensed to companies in regulated markets. AmeriCann, Inc. is a
Certified B Corp, an acknowledgment of the company's commitment to social and
environmental ethics, transparency and accountability. AmeriCann became the
first public cannabis company to earn this respected accreditation.
Amfil Technologies Inc. (OTC:
AMFE) focuses primarily on the acquisition of income
generating private companies and optimizing their operations under the Amfil
Technologies umbrella. Amfil is focused on growing
shareholder value by allowing investors access to self-sustaining small to
medium sized businesses with proven profitable strategies, and identified as
having substantial potential for future growth. Amfil seeks to achieve
long-term financial returns consisting of regular dividend income, benefiting
from preferential tax treatment, and expecting modest mid-to-long term capital
growth. Amfil Technologies primarily invests in small to mid-sized companies
with above average service capacity, growth potential or existing market share.
GROzone: The GROzone systems are a triple function
sanitization unit capable of naturally eliminating 99.9% of gaseous and aqueous
pathogens developed for the Medical Marijuana Industry.
AMFE) focuses primarily on the acquisition of income
generating private companies and optimizing their operations under the Amfil
Technologies umbrella. Amfil is focused on growing
shareholder value by allowing investors access to self-sustaining small to
medium sized businesses with proven profitable strategies, and identified as
having substantial potential for future growth. Amfil seeks to achieve
long-term financial returns consisting of regular dividend income, benefiting
from preferential tax treatment, and expecting modest mid-to-long term capital
growth. Amfil Technologies primarily invests in small to mid-sized companies
with above average service capacity, growth potential or existing market share.
GROzone: The GROzone systems are a triple function
sanitization unit capable of naturally eliminating 99.9% of gaseous and aqueous
pathogens developed for the Medical Marijuana Industry.
Aphria Inc (TSX: APH.TO; OTC:APHQF) Aphria is a leading global cannabis company
driven by an unrelenting commitment to our people, product quality and
innovation. Headquartered in Leamington, Ontario – the greenhouse capital of
Canada – Aphria has been setting the standard for the low-cost production of
safe, clean and pure pharmaceutical-grade cannabis at scale, grown in the most
natural conditions possible. Focusing on untapped opportunities and backed by
the latest technologies, Aphria is committed to bringing breakthrough
innovation to the global cannabis market. The Company's portfolio of brands is
grounded in expertly-researched consumer insights designed to meet the needs of
every consumer segment. Rooted in our founders' multi-generational expertise in
commercial agriculture, Aphria drives sustainable long-term shareholder value
through a diversified approach to innovation, strategic partnerships and global
expansion, with a presence in more than 10 countries across 5 continents
driven by an unrelenting commitment to our people, product quality and
innovation. Headquartered in Leamington, Ontario – the greenhouse capital of
Canada – Aphria has been setting the standard for the low-cost production of
safe, clean and pure pharmaceutical-grade cannabis at scale, grown in the most
natural conditions possible. Focusing on untapped opportunities and backed by
the latest technologies, Aphria is committed to bringing breakthrough
innovation to the global cannabis market. The Company's portfolio of brands is
grounded in expertly-researched consumer insights designed to meet the needs of
every consumer segment. Rooted in our founders' multi-generational expertise in
commercial agriculture, Aphria drives sustainable long-term shareholder value
through a diversified approach to innovation, strategic partnerships and global
expansion, with a presence in more than 10 countries across 5 continents
Get the full list as an Investor ideas member , plus get weekly updates
with new pot stocks added and get the daily potcast for Investor Ideas #Potcasts #Cannabis News and Stocks on the Move.
with new pot stocks added and get the daily potcast for Investor Ideas #Potcasts #Cannabis News and Stocks on the Move.
Learn more https://www.investorideas.com/membership/
Investor Ideas
stock directory of publicly traded CSE, TSX,
TSXV, OTC, NASDAQ, NYSE, ASX Marijuana / Hemp Stocks
stock directory of publicly traded CSE, TSX,
TSXV, OTC, NASDAQ, NYSE, ASX Marijuana / Hemp Stocks
Investor Ideas #Potcasts #Cannabis News and Stocks on the
Move:
Move:
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also available on
iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word
mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration
Number: 10468217708
mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration
Number: 10468217708
About Investorideas.com - News that Inspires
Big Investing Ideas
Big Investing Ideas
Investorideas.com is a recognized news source
publishing third party news and press releases plus we create original
financial content. Learn about investing in stocks and sector trends
from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto,
technology including AI and IoT ,
mining ,sports biotech, water, renewable energy and more . Investorideas.com
original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and
stock news column, Investor
Ideas #Potcasts #Cannabis News and
Stocks on the Move podcast and column,
Cleantech and Climate Change Podcast and
the Stock Guru daily podcast on Support and Resistance Trading.
publishing third party news and press releases plus we create original
financial content. Learn about investing in stocks and sector trends
from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto,
technology including AI and IoT ,
mining ,sports biotech, water, renewable energy and more . Investorideas.com
original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and
stock news column, Investor
Ideas #Potcasts #Cannabis News and
Stocks on the Move podcast and column,
Cleantech and Climate Change Podcast and
the Stock Guru daily podcast on Support and Resistance Trading.
Disclaimer/Disclosure: Investorideas.com is
a digital publisher of third party sourced news, articles and equity research
as well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases or
sale of stocks, services or products. Nothing on our sites should be construed
as an offer or solicitation to buy or sell products or securities. All
investment involves risk and possible loss of investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Contact each company directly regarding
content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp.
a digital publisher of third party sourced news, articles and equity research
as well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases or
sale of stocks, services or products. Nothing on our sites should be construed
as an offer or solicitation to buy or sell products or securities. All
investment involves risk and possible loss of investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Contact each company directly regarding
content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp.
Additional info
regarding BC Residents and global Investors: Effective September 15 2008 - all
BC investors should review all OTC and Pink sheet listed companies for
adherence in new disclosure filings and filing appropriate documents with
Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations
of each country.
regarding BC Residents and global Investors: Effective September 15 2008 - all
BC investors should review all OTC and Pink sheet listed companies for
adherence in new disclosure filings and filing appropriate documents with
Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations
of each country.
Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Follow us on Social Media
Contact Investorideas.com
800-665-0411
No comments:
Post a Comment